Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class therapies ...

For more than 25 years, the US has been hell-bent on overthrowing the Bolivarian Revolution. Unable to see its surrogates succeed at the polls or trigger an outright coup, Washington settled on a ...

Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up to date, and accurate. Susan ...